Newsletter | Qlife

2019-10-16 16:20

We have just launched our Qlife investor site, which allows you to find relevant news, details and information about
Qlife Holding AB and the upcoming IPO.

In the enclosed Newsletter you will find updated information about our operations and preparations for next steps.

Qlife_pressmeddelande_19_10_16_0.pdf (530.5 KB)

2025-10-05 17:00

The Letter of Intent with Hipro Biotechnology Co., Ltd. regarding reverse takeover has been extended

2025-09-22 18:00

Qlife Holding AB announces the outcome of the exercise of warrants series TO 6

2025-09-15 08:30

Qlife announces additional product line and progresses two new tests into clinical trials

2025-08-27 08:30

QLIFE HOLDING AB, Interim Report Q2, April to June 2025

2025-08-27 08:00

Progress update on the reverse takeover process between Qlife and Hipro

2025-08-21 18:22

Qlife Holding AB increases existing credit facility and extends the maturity date

2025-08-21 09:13

Qlife together with Birmingham Women’s and Children’s NHS Foundation Trust achieve positive results for its rare disease self-test PHE product

2025-08-21 08:30

Qlife together with Birmingham Women’s and Children’s NHS Foundation Trust achieve positive results for its rare disease self-test PHE product

2025-07-09 22:09

Qlife resolves to carry out a directed set-off issue of approximately SEK 2.47 million in accordance with previously announced credit facility agreement